首页> 外文期刊>Life sciences >Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance.
【24h】

Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance.

机译:持续暴露于阿片类药物可促进疼痛:与阿片类药物抗伤害感受性的关系。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Opioid analgesics are frequently used for the long-term management of chronic pain states, including cancer pain. The prolonged use of opioids is associated with a requirement for increasing doses to manage pain at a consistent level, reflecting the phenomenon of analgesic tolerance. It is now becoming clearer that patients receiving long-term opioid therapy can develop unexpected abnormal pain. Such paradoxical opioid-induced pain, as well as tolerance to the antinociceptive actions of opioids, has been reliably measured in animals during the period of continuous opioid delivery. Several recent studies have demonstrated that such pain may be secondary to neuroplastic changes that result, in part, from an activation of descending pain facilitation mechanisms arising from the rostral ventromedial medulla (RVM). One mechanism which may mediate such pain facilitation is through the increased activity of CCK in the RVM. Secondary consequences from descending facilitation may be produced. For example, opioid-induced upregulation of spinal dynorphin levels seem to depend on intact descending pathways from the RVM reflecting spinal neuroplasticity secondary to changes at supraspinal levels. Increased expression of spinal dynorphin reflects a trophic action of sustained opioid exposure which promotes an increased pain state. Spinal dynorphin may promote pain, in part, by enhancing the evoked release of excitatory transmitters from primary afferents. In this regard, opioids also produce trophic actions by increasing CGRP expression in the dorsal root ganglia. Increased pain elicited by opioids is a critical factor in the behavioral manifestation of opioid tolerance as manipulations which block abnormal pain also block antinociceptive tolerance. Manipulations that have blocked enhanced pain and antinociceptive tolerance include reversible and permanent ablation of descending facilitation from the RVM. Thus, opioids elicit systems-level adaptations resulting in pain due to descending facilitation, upregulation of spinal dynorphin and enhanced release of excitatory transmitters from primary afferents. Adaptive changes produced by sustained opioid exposure including trophic effects to enhance pain transmitters suggest the need for careful evaluation of the consequences of long-term opioid administration to patients.
机译:阿片类镇痛药经常用于慢性疼痛状态(包括癌症疼痛)的长期治疗。阿片类药物的长期使用与增加剂量以稳定水平地控制疼痛有关,这反映出止痛耐受现象。现在越来越清楚的是,长期接受阿片类药物治疗的患者会出现意想不到的异常疼痛。在连续的阿片类药物输送期间,已经在动物中可靠地测量了这种自相矛盾的阿片类药物引起的疼痛以及对阿片类药物的镇痛作用的耐受性。最近的一些研究表明,这种疼痛可能是神经塑性改变的继发性改变,这种改变的部分原因是由延髓腹侧延髓(RVM)引起的下行疼痛促进机制的激活。可以介导这种疼痛缓解的一种机制是通过RVM中CCK活性的增加。下降的便利可能产生次要后果。例如,阿片类药物诱导的脊柱强啡肽水平的上调似乎取决于RVM的完整下降途径,反映了继上脊柱水平改变后脊柱神经可塑性。脊髓强啡肽表达的增加反映了持续的阿片样物质暴露的营养作用,从而促进了疼痛状态的加剧。脊柱强啡肽可通过增强原发传入兴奋性递质的释放来促进疼痛。在这方面,阿片类药物还可以通过增加背根神经节中CGRP的表达来产生营养作用。阿片类药物引起的疼痛增加是阿片类药物耐受行为表现的关键因素,因为阻断异常疼痛的操作也会阻断抗伤害感受性耐受。阻碍疼痛和抗伤害感受耐受性增强的操作包括可逆性和永久性消融RVM引起的下降促进作用。因此,阿片类药物引起系统水平的适应性变化,这归因于简化性的下降,脊髓强啡肽的上调和增强的兴奋性递质从原发受体的释放,从而导致疼痛。持续服用阿片类药物所产生的适应性变化(包括增强疼痛传递者的营养作用)表明,需要仔细评估长期服用阿片类药物对患者的后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号